Human Umbilical Cord Blood Mesenchymal Stem Cells Ameliorate Autism‐Like Behaviors in a Valproic Acid‐Induced Mouse Model via the IGF‐1/Akt Signaling Pathway
Brain and Behavior · 2026
DOI: 10.1002/brb3.71335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2026. Verfasst von Jie Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Proto-Oncogene Proteins c-akt, Mesenchymal Stem Cell Transplantation, Autistic Disorder. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Provincial Natural Science Foundation and Shiyan Innovation and Development Joint Foundation of China, Open Fund Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, the Supported by the Open Fund Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital.
Abstract (Originalsprache)
Background
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder that significantly impacts children's physical and mental health, yet effective pharmacological treatments remain limited. The primary objective of this study was to investigate the therapeutic effects of human umbilical cord blood mesenchymal stem cells (hUC‐MSCs) on ASD, evaluate the safety profile of hUC‐MSCs, and elucidate their underlying mechanisms and functional roles.
Methods
In this study, we utilized the offspring of pregnant mice exposed to valproic acid (VPA) as an animal model of ASD. At the beginning of 5 weeks of age, 5 × 10 5 hUC‐MSCs were administered into the lateral ventricles to evaluate their safety profile and elucidate their potential roles and underlying mechanisms. Specifically, we first monitored the growth and overall health status of the mice following hUC‐MSC treatment and assessed potential toxic effects by performing H&E staining on major organs. Second, behavioral analyses were conducted to examine changes in social interaction, repetitive and stereotyped behaviors, and anxiety‐like behaviors in young mice before and after hUC‐MSC intervention. Finally, the mechanisms underlying the therapeutic effects of hUC‐MSCs in ASD were explored using techniques such as RT‐PCR, Western blot analysis, brain tissue staining, and neuron culture experiments.
Results
Here, we demonstrate that hUC‐MSCs effectively mitigate behavioral abnormalities in a VPA‐induced mouse model of autism without notable adverse effects. Mechanistically, hUC‐MSC treatment promotes cortical neuronal dendritic development and restores the phosphorylation levels of insulin‐like growth factor 1 receptor (IGF‐1R) and protein kinase B (Akt). Furthermore, mRNA expression of synaptic plasticity‐associated genes GAP‐43 and SYP, as well as the anti‐inflammatory cytokine IL‐10, was significantly upregulated, while the expression of proapoptotic genes Bax and Caspase‐3, along with pro‐inflammatory cytokines IL‐6 and IL‐1β, was markedly suppressed.
Conclusions
These findings suggest that hUC‐MSCs may exert neuroprotective effects by modulating the IGF‐1/Akt signaling pathway, promoting neuronal development, reducing neuroinflammation, and inhibiting apoptosis, ultimately alleviating core ASD‐like symptoms. The therapeutic benefits may stem from paracrine factors secreted by hUC‐MSCs or their ability to regulate gene expression linked to neuronal development. Our study provides new insights into ASD pathogenesis and highlights the potential of hUC‐MSCs as a novel stem cell‐based therapy for ASD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Institute of Pediatric Research, Hubei University of Medicine, Shiyan, Hubei, China.
- Hubei Provincial Clinical Research Center For Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Pediatrics, First Clinical School, Hubei University of Medicine, Shiyan, Hubei, China.
Förderung
- Hubei Provincial Natural Science Foundation and Shiyan Innovation and Development Joint Foundation of China
- Open Fund Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital
- the Supported by the Open Fund Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital
- the Joint supported by Hubei Provincial Natural Science Foundation and Shiyan Innovation and Development Joint Foundation-of China
Zitieren
APA
Tian, J., Deng, H., Hu, Z., He, G., Zhang, J., Jiang, F., Xu, J., Wu, Y., Jiang, H., Zhang, R., Ren, L., & Gu, J. (2026). Human Umbilical Cord Blood Mesenchymal Stem Cells Ameliorate Autism‐Like Behaviors in a Valproic Acid‐Induced Mouse Model via the IGF‐1/Akt Signaling Pathway. Brain and Behavior. https://doi.org/10.1002/brb3.71335
Vancouver
Tian J, Deng H, Hu Z, He G, Zhang J, Jiang F, et al. Human Umbilical Cord Blood Mesenchymal Stem Cells Ameliorate Autism‐Like Behaviors in a Valproic Acid‐Induced Mouse Model via the IGF‐1/Akt Signaling Pathway. Brain and Behavior. 2026. doi:10.1002/brb3.71335
BibTeX
@article{Tian2026,
author = {Tian, Jie and Deng, Hujing and Hu, Zhoujing and He, Guangzhen and Zhang, Juan and Jiang, Feiyang and Xu, Jinyun and Wu, Yong and Jiang, Hao and Zhang, Ruibo and Ren, Lan and Gu, Jiaowei},
title = {Human Umbilical Cord Blood Mesenchymal Stem Cells Ameliorate Autism‐Like Behaviors in a Valproic Acid‐Induced Mouse Model via the IGF‐1/Akt Signaling Pathway},
journal = {Brain and Behavior},
year = {2026},
doi = {10.1002/brb3.71335}
}
EUVIMED